Biosimilars: Ensuring quality, safety, and performance of follow-on biologics

Philadelphia, USA (November 11-13, 2008)

The conference will provide practical insights into the scientific developments and regulatory challenges that will influence the success of biosimilars/follow-on biologics market.

Consideration will be given to the evaluation of unwanted immunogenicity of follow-on biologicals, from preclinical development, through clinical trials, and into the post-registration period to minimise the risks associated with immunogenicity in recipients of therapeutic products.

More: http://www.biotechnology-europe.com/events/by%20company/Visiongain/4th